Perceptive Informatics, a unit of biopharmaceutical services company Parexel International Corp. (PRXL), Monday said it entered into a license agreement with the EuroQoL Group that allows Perceptive to provide EQ-5D through its Electronic Patient Reported Outcomes or ePRO solution in an Interactive Voice Response or IVR format.
EQ-5D is a standardized instrument to measure health-related quality of life outcomes and is non-disease specific. With 83 official language versions of EQ-5D, the instrument can be used in a wide array of geographies for global clinical programs.
Perceptive Informatics is among the first organizations in the industry to offer the EQ-5D instrument in an ePRO-IVR format. This offers an intuitive interface for capturing patient reported data, ranging from diaries and validated instruments to complex clinical assessments.
The agreement provides clinical study sponsors the ability to collect health-related quality of life patient reported outcomes data via the telephone, using Perceptive's ePRO solution in an IVR format. The instrument allows for easy completion of required data by study participants. It provides a descriptive profile and a single index value for a particular health status.
Patients can use the Perceptive ePRO system by dialing a toll-free number where they access an application delivered in their own language. Applications are designed to facilitate rapid progression through questions, and responses can be entered easily by using a telephone key pad. Study sponsors and investigator sites can access ePRO data and diary compliance metrics in real time via an online web reporting capability.
PRXL closed Friday's regular trade at $9.90, up from the previous close of $9.71, on 410,800 shares.
For comments and feedback: editorial@rttnews.com